Register Now CME Webinar
___________________________________
Denied Due to Lack of Medical Necessity:
Preventing & Responding to Insurance Denials for PANS/PANDAS Treatments
Hosted by PANDAS Physicians Network
Presented by Elizabeth Irias, LMFT
PANS/PANDAS CLINICIAN RESOURCES
FLOWCHARTS
Follow the process for determining the appropriate diagnosis and symptom severity based treatment protocols for mild, moderate, and severe/extreme cases.
TREATING PANS/PANDAS
Access information on treating PANS and PANDAS with antimicrobials, immunomodulatory therapy, and psychotherapeutic and behavioral therapy.
SEEING YOUR FIRST PATIENT
This publication helps clinicians new to PANS/PANDAS by providing an overview, symptoms and diagnostic criteria, workup recommendations, and expectations.
NEW: NIH FUNDS PANS AND PANDAS RESEARCH
NIH-funded research project
Elucidating the role of RXRA in the myeloid lineage in post-infectious basal ganglia encephalitis
PI/Project Leader: Dritan Agalliu, PhD
Associate Professor of Pathology and Cell Biology (in Neurology), Columbia University Irving Medical Center
NIH-funded research project
Anti-interneuron antibodies in rapid-onset pediatric OCD: clinical generalization and target identification
PI/Project Leader: Christopher Pittenger, MD, PhD
Professor of Psychiatry at Yale University, Assistant Chair for Translational Research in Psychiatry, and Director of the Clinical Neuroscience Research Unit , the Neuroscience Research Training Program (NRTP, the research track of the Yale adult psychiatry residency), the Yale OCD Research Clinic, and the new Yale Program in Psychedelic Science
NEW PAPER:
Neuroinflammation in Obsessive-Compulsive Disorder:
Sydenham Chorea, Pediatric Autoimmune Neuropsychiatric Disorders Associated with Streptococcal Infections, and Pediatric Acute Onset Neuropsychiatric Syndrome
RECENT ONSET OF PANS/PANDAS?
Your patient may qualify for a treatment study.
Patients 6-17 years old may qualify to participate in research that will help determine the sustainability of the reduction of the severity of symptoms in children treated with IVIG. All participants will receive the study drug and placebo. Help with travel expenses provided.
OUR MISSION
The PPN mission is to maintain the industry standard PPN Guidelines for Diagnostics and Therapeutics, foster continuous education and communication within the multi-disciplinary medical community and to sponsor research for developing diagnostic tests, treatment protocols and a cure for PANDAS/PANS within this generation.
BECOME A MEMBER
► Receive email alerts on new research, guidelines, and treatment protocols
► Option to be recognized as a practitioner who works with PANS/PANDAS patients
► Become eligible to apply for a research grant
► Receive occasional members only benefits
ADVISORY COMMITTEES
Public Health Advisory Committees for PANDAS and PANS are done through a collaboration of health care and community-based partnerships. The list of committees are organized by state.